中药企业申报FDA认证影响因素研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Study on Influencing Factors of Traditional Chinese Medicine Enterprises Applying for FDA Certification
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    运用扎根理论分析中药企业申报FDA(美国食品药品监督管理局)认证的影响因素,并构建理论模型,为中药企业制定科学的战略决策提供参考。在中国知网搜集申报、未申报FDA认证企业战略决策者的访谈资料,对这些访谈资料进行扎根编码。经过开放式编码、主轴编码、选择编码和对比验证,最终梳理出27个开放编码、9个范畴和5个主范畴,在分析各范畴逻辑关系的基础上构建理论模型。中药企业申报FDA认证是建立在对FDA标准和中药现代化、国际化具有一致性认知基础上的,不仅要达成以药品身份进入欧美市场的目标,还要在申报过程中促进企业升级,提升中药产业现代化水平,实现可持续发展。

    Abstract:

    Grounded theory was used to analyze the influencing factors of Chinese medicine enterprises applying for FDA(Food and Drug Administration) certification in the United States, and a theoretical model was constructed to provide reference for Chinese medicine enterprises to make scientific strategic decisions. Interview data from strategic decision-makers of companies that have applied for and have not applied for US FDA certification was collected on CNKI, and then root code. After open coding, spindle coding, selection coding, and comparative verification, 28 open coding, 9 categories, and 5 main categories were finally sorted out, and a theoretical model was constructed based on the analysis of the logical relationship between each category. The strategic decision of traditional Chinese medicine enterprises to apply for FDA certification is based on a consistent understanding of FDA standards and the modernization and internationalization of traditional Chinese medicine. It not only aims to enter the European and American markets as a drug, but also promotes enterprise upgrading, enhances the modernization level of the traditional Chinese medicine industry, and achieves sustainable development during the application process.

    参考文献
    相似文献
    引证文献
引用本文

赵锡锋.中药企业申报FDA认证影响因素研究[J].科技与产业,2025,25(03):196-202

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-02-25
×
《科技和产业》
喜报 | 学会期刊《科技和产业》成为国家哲学社会科学文献中心2024年度最受欢迎的经济学期刊